Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Clinical trial NCT05294666 · COMPLETED

Trial details

NCT number: NCT05294666
Sponsor: Peking University Third Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Graft Versus Host Disease in Eye

Start date: 2020-04-01
Primary completion: 2021-06-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.